Words of wisdom. Re: management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery

Affiliations

Comment

Michael A S Jewett. Eur Urol. 2011 May.

. 2011 May;59(5):880-1.

doi: 10.1016/j.eururo.2011.02.013.

¹ Division of Urology, Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada. m.jewett@utoronto.ca

No abstract available

Comment on

Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery.
Kollmannsberger C, Daneshmand S, So A, Chi KN, Murray N, Moore C, Hayes-Lattin B, Nichols C. Kollmannsberger C, et al. J Clin Oncol. 2010 Feb 1;28(4):537-42. doi: 10.1200/JCO.2009.23.0755. Epub 2009 Dec 21. J Clin Oncol. 2010. PMID: 20026807
Long-term follow-up of Cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?
Ehrlich Y, Brames MJ, Beck SD, Foster RS, Einhorn LH. Ehrlich Y, et al. J Clin Oncol. 2010 Feb 1;28(4):531-6. doi: 10.1200/JCO.2009.23.0714. Epub 2009 Dec 21. J Clin Oncol. 2010. PMID: 20026808